Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease
Objective: To evaluate the effect of melatonin on nocturia. Background: Nocturia is one of the commonest non motor symptoms in Parkinsons’ disease (PD), and has…Assessment of Autonomic Dysfunction in Parkinson’s Disease
Objective: Assessment of autonomic dysfunction in patients with Parkinson's disease and further comparison with patients without autonomic symptoms Background: A frequent disabling complication of Parkinson’s…Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease
Objective: To evaluate the association between melatonin secretion rhythm and nocturnal polyuria, and the pathophysiology of nocturnal polyuria in PD. Background: Patients with PD have…Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease
Objective: To investigate the relationship between urinary dysfunction (UD) and anxiety and depression in Parkinson's Disease (PD). Background: Urinary dysfunction is one of the…Parkinson’s Disease and Urogenital Dysfunction
Objective: The aim of this study is to identify the involvement of urogenital functions in PD. Background: Urogenital dysfunction could occur in neurological diseases due to central…Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?
Objective: To present the prefrontal cortex activity in patients with Parkinson's disease (PD) and evaluated the association between prefrontal cortex and lower urinary tract dysfunction…Parasacral effects of electrical stimulation on lower urinary tract symptoms and constipation in patients with Parkinson’s disease: Preliminary data
Objective: To evaluate the effectiveness of parasacral electrostimulation in symptoms of lower urinary tract and constipation, besides the urodynamic parameters in patients with Parkinson's disease.…Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry
Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients
Objective: To explore the association between levels of α-synuclein burden and urinary dysfunction in early de novo (untreated) Parkinson's disease (PD) patients. Background: Urinary dysfunction…GAA expansion with clinic/urodynamic findings in Friedreich’s ataxia with LUTS
Objective: This study correlate the number of GAA repetitions of alleles, the duration of the disease, and the age at the onset of the disease…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.